Gapping down
In reaction to disappointing earnings/guidance: FIO -15.3%, SYMC -13.1%, ANGI -12.3%, TQNT -11%, AKAM -9.8%, KFN -7.1%, VAR -7%, WRLD -6.3%, (light volume), FORM -6%, ALV -5.7%, ORLY -5.4%, EGHT -5.2%, TKR -5.2%, (light volume), XRX -4.5%, DOW -3.5%, TER -3.3%, ETFC -3.1%, DNKN -3%, SKX -3%, (light volume), CS -3%, SIRI -3%, ESI -2.8%, (light volume), LSI -2.7%, GNC -2.2%, CVA -2.1% (light volume), DO -1.9%, (light volume), UA -1.6%, POT -1.3%, TRIP -1.3%, MLNX -1.1%, CMO -0.9% (light volume), IP -0.5%, (light volume).
Other news: NVDQ -6% (announces public offering of common shares; size not disclosed), ZIOP -5.7% (prices public offering of 14.3 mln shares of its common stock at $3.50 per share), RIGL -5.6% (Rigel Pharma provides pipeline update; R333 did not meet the primary endpoint in a recently completed Phase 2 clinical study; co has decided not to pursue this indication further with R333), SWKS -1.8% (following TQNT results), NOK -1.8% and DEO -1.1% (still checking), ZINC -1% (announces public offering 5 mln shares of common stock).
Analyst comments: USB -0.6% (U.S. Bancorp downgraded to Hold from Buy at Deutsche Bank).